2017 Press Releases

Webcast ImageWebcast
RBC Capital Markets 2017 Global Healthcare Conference (Replay)
02/22/17 at 10:30 a.m. ET
RBC Capital Markets 2017 Global Healthcare Conference
Wednesday, February 22, 2017 10:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle  
02/15/17Editas Medicine Announces U.S. Patent and Trademark Office Decision Favorable to Broad Institute in CRISPR Interference
CAMBRIDGE, Mass., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT) announced today that the U.S. Patent and Trademark Office (USPTO) issued a favorable decision in the CRISPR interference between the University of California, the University of Vienna, Emmanuelle Charpentier and the Broad Institute, Inc. (Broad) regarding certain CRISPR-Cas9 patents the Company exclusively licenses from Broad. The USPTO granted Broad’s Motion for No Interference in Fact, ending the interfer... 
Download PDFPrinter Friendly Version
02/10/17Editas Medicine to Present at Upcoming February Investor Conferences
CAMBRIDGE, Mass., Feb. 10, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will present a company overview at two upcoming investor conferences in February.  Details of the presentations are as follows: 19th Annual BIO CEO & Investor Conference Date: Monday, February 13, 2017 Time: 3:00 p.m. ET Location: New York City     ... 
Download PDFPrinter Friendly Version
01/09/17Editas Medicine Reports on Recent Progress and 2017 Goals at J.P. Morgan Healthcare Conference
-    Company Achieves In Vivo Proof-of-Editing in the Retina of Non-Human Primates    -  -    Unparalleled Genome Editing Platform Includes Cpf1 and Advanced Forms of Cas9    - CAMBRIDGE, Mass., Jan. 09, 2017 (GLOBE NEWSWIRE) -- In a presentation to investors on Wednesday, January 11, 2017 at 11:30am (PST) at the 35th Annual J.P. Morgan Healthcare Conference, Editas Medicine, Inc. (NASDAQ:EDIT) President and CEO Katrine Bosley will outline the Company’s progress on developing medicines a... 
Download PDFPrinter Friendly Version
01/04/17Editas Medicine to Present at the 35th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will present a company overview followed by a question and answer session at the 35th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2017, at 11:30 a.m. PT in San Francisco, CA. A live webcast of the presentation and question and answer session will be available on the Investors & Media section of the Editas website at www.edi... 
Download PDFPrinter Friendly Version
Print Page    E-mail Page    RSS    E-mail Alerts